Intermagnetics reports strong growth

Article

Intermagnetics General continued an upward financial ride throughthe first half of fiscal 1996. The Latham, NY, maker of superconducting magnets, wire andfreon-replacement refrigerants reported second-quarter revenuesof $23.7 million, up 18% from the

Intermagnetics General continued an upward financial ride throughthe first half of fiscal 1996.

The Latham, NY, maker of superconducting magnets, wire andfreon-replacement refrigerants reported second-quarter revenuesof $23.7 million, up 18% from the second quarter of fiscal 1995.Sales of $45 million for the first half of the fiscal year wereup 25% from the year before.

Quarterly net income of $1.1 million was 36% higher than second-quarter1994 results. Through the first half of fiscal 1995, earningsincreased 72% to $1.8 million.

Intermagnetics' earnings improved despite a 24% decline insecond-quarter margins, according to CEO Carl Rosner. He blamedthe downturn on magnet and wire price reductions, lower wire productionyields, a change in sales mix, and substantial rework costs forcryogenic products.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.